Top news of the week: 09.08.2022.
Samantha Truex on biotech hiring, competing for funding and Upstream’s next steps
The CEO recently led Upstream through a $200 million financing that will support development of an inflammatory disease drug. “We have what investors probably want at this time,” she told ...
Strand CEO on founder-led biotech, venture capital and the market’s retreat
Belite's shares have risen nearly 500% from their IPO price at a time when many other newly public biotech companies are struggling to hold their value. The companies pitch their …
Biotech Venture Funding, Valuations Hold Up, But Challenges Loom
U.S. and European biotech startups raised $17.1 billion in the first half, putting 2022 slightly behind the record-setting pace of 2021, according to Silicon Valley Bank.
AbCellera inks another venture partnership, this time with Atlas
One week after striking a deal with Versant, the antibody specialist is teaming up with Atlas to provide drug candidates to an undisclosed startup backed by the biotech investor.
How a small UK biotech ended up in Gilead’s hands
MiroBio, which was spun out of the University of Oxford three years ago, drew Gilead’s interest with its autoimmune disease research.
Helping Biopharma Overcome the Challenges to Go Digital
Despite much interest, digitizing manufacturing is still far from straightforward for biopharmaceutical firms used to more traditional production methods.
August 3, 2022
Arcutis: FDA Approves ZORYVE (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older More Celularity: Treatment of First Patient in Phase …